10.6084/m9.figshare.c.3672760_D2.v1
Tereza Lanitis
Tereza
Lanitis
Robert Leipold
Robert
Leipold
Melissa Hamilton
Melissa
Hamilton
Dale Rublee
Dale
Rublee
Peter Quon
Peter
Quon
Chantelle Browne
Chantelle
Browne
Alexander Cohen
Alexander
Cohen
Additional file 1: of Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences
Springer Nature
2017
Venous thromboembolism
Apixaban
Vitamin K antagonists
Cost-effectiveness
2017-01-23 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Cost-effectiveness_of_apixaban_versus_low_molecular_weight_heparin_vitamin_k_antagonist_for_the_treatment_of_venous_thromboembolism_and_the_prevention_of_recurrences/4580434
The objective of this appendix is to provide additional technical documentation to the manuscript detailing the model calculations and data used to calculate the transition matrix in the model. (DOCX 26Â kb)